Diagnostic Value of Serum Levels of IL-22, IL-23, and IL-17 for Idiopathic Pulmonary Fibrosis Associated with Lung Cancer
Qian Zhang,Lihong Tong,Bing Wang,Ting Wang,Hongxia Ma
DOI: https://doi.org/10.2147/TCRM.S349185
2022-04-20
Therapeutics and Clinical Risk Management
Abstract:Qian Zhang, Lihong Tong, Bing Wang, Ting Wang, Hongxia Ma Pneumology Department, The Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi City, People's Republic of China Correspondence: Hongxia Ma, Pneumology Department, The Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University, Urumqi City, The Xinjiang Uygur Autonomous Region, 830000, People's Republic of China, Email Background: Correlations between idiopathic pulmonary fibrosis (IPF) and lung cancer have been discussed in many previous studies. In the present work, we evaluated the potential diagnostic value of serum levels of Th17 cell-related cytokines for the detection of lung cancer-associated IPF. Methods: Fifty-six patients who had been diagnosed with lung cancer-associated IPF were enrolled, and 59 patients with lung cancer but without IPF were also enrolled, and 60 healthy volunteers were served as the control group. The expression of IL-22, IL-23, and IL-17 was evaluated by enzyme-linked immunosorbent assay (ELISA) kits. Results: We observed that IL-22, IL-23 as well as IL-17 were significantly increased in the serum of lung cancer patients associated IPF; moreover, the results of ROC curve showed that the expression of IL-22, IL-23 and IL-17 can distinguish the lung cancer patients with lung cancer-associated IPF group; finally, the expression of IL-22, IL-23 and IL-17 was positively correlated with the degree of differentiation and metathesis of the tumor. Conclusion: In conclusion, we first reported that IL-22, IL-23 and IL-17 were elevated in the serum of patients with lung cancer-associated IPF, and our data may provide novel evidence for the prevention and treatment of lung cancer-associated IPF. Graphical Keywords: idiopathic pulmonary fibrosis, diagnosis, IL-22, IL-23, IL-17, lung cancer Graphical Idiopathic pulmonary fibrosis (IPF) is known as an inflammation-associated lung disease. It has been characterized by the long-term inflammatory condition and infiltration of immune cells, as well as the aberrant collagen deposition, which leads to the remodeling of the lung. 1–3 Although the pathogenesis of IPF remains unclear, the results of previous studies suggested that IPF may initiate from a lesion that locates at the alveolus, and the long-term inflammatory condition could further lead to damages on the structure within the alveolar, including aberrant apoptosis of type I epithelial cells, over-proliferation of the type II cells, as well as the thickening of small airways and the artery walls. 4–6 It is believed that damage to the alveolar parenchymal tissue could consequentially induce the fibrotic condition in the alveolar walls and remodeling of the lung tissue. Based on the results of previous studies, idiopathic pulmonary fibrosis was considered as an important risk factor for the progression of lung cancer. 7–9 It has been estimated that the incidence rate of lung cancer associated IPF patients ranges from about 10% to 40%. Unfortunately, lung cancer has also become a major contributor to IPF related-death among the above patients 10–12 and the prognosis for patients with IPF associated lung cancer remains poor. CD4+ T helper cells (CD4+ T cells) were known as regulators of many immune responses. CD4+ T cells were first divided into two subgroups, Th1 and Th2, based on the cytokines they expressed. In recent years, the investigation of Th17, a new subgroup of CD4+ T cells, has become a hot field. Th17 cells were known to produce interleukin-17, as well as other cytokines, for example, IL-22 and IL-21. 13,14 IL-17 is known as a cytokine that participates in many immune diseases, for example, autoimmune diseases. The secretion of IL-17 is affected by several factors, for example, interleukin-23 (IL-23). IL-23 is mainly produced by dendritic cells as well as macrophages. 15 Previous studies have suggested that IL-23 and IL-17 may play important roles in different types of cancers, including lung cancer. On the other hand, the aberrant expressions of the above cytokines were also found in patients with idiopathic pulmonary fibrosis; however, whether Th-17 related cytokines may serve as a biomarker for the early diagnosis of patients with combined idiopathic pulmonary fibrosis and lung cancer remains unclear. This study was designed to test the hypothesis that one or more early serum biomarkers for idiopathic pulmonary fibrosis combined with lung cancer in the general Chinese population, recruited patients who signed informed consent while staying in hospital and was carried out according to the Declaration of Helsinki guidelines, and authorized by the ethics committee. Our data may provi -Abstract Truncated-
health care sciences & services